Antal Rohit Desai bought $10M of PRCT
director at PROCEPT BioRobotics Corp. 426,262 shares at an average of $24.59, traded Mar 5, 2026, filed Mar 9, 2026.
Score components
- +15RoleDirector
- +25Trade size$10.5M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context61% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.5%, 3m +12.2%, 6m -9.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-26-001209, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +142,498 | $25.44 | $3.6M | 142,498 | Mar 9, 2026 |
| Mar 5, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +24,748 | $26.41 | $654k | 167,246 | Mar 9, 2026 |
| Mar 6, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +106,554 | $23.33 | $2.5M | 273,800 | Mar 9, 2026 |
| Mar 6, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +53,763 | $24.10 | $1.3M | 327,563 | Mar 9, 2026 |
| Mar 9, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +43,581 | $24.08 | $1.0M | 371,144 | Mar 9, 2026 |
| Mar 9, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +53,818 | $24.91 | $1.3M | 424,962 | Mar 9, 2026 |
| Mar 9, 2026 | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +1,300 | $25.42 | $33k | 426,262 | Mar 9, 2026 |
Related signals
Other insiders at PROCEPT BioRobotics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $6,223 297 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $7,815 373 shares | -0% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $7,815 373 shares | -0% | |
| 59Moderate | PRCTbuy PROCEPT BioRobotics Corp | Larry L Wood President, CEO | $498k 23,900 shares | - | |
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,117 285 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $10k 358 shares | -1% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $10k 357 shares | -0% | |
| 23Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,559 304 shares | -0% | |
| 14Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $139k 5,363 shares | -5% | |
| 30Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $20k 706 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.